WilliamT.KoMDFAAD

Dermatologic Surgery

President - Arizona Dermatology Group External Partnership Director - Biomarck Pharmaceuticals Scientific Advisory Board - Biomarck Pharmaceuticals Researcher - Arizona Research Center Clinical Preceptor - AT Still University Clinical Preceptor Midwestern University

Join to view full profile

Dr. Ko is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Ko's full profile

Already have an account?

Office
4835 e cactus rd
155
Scottsdale, AZ 85254
Phone+1 602-996-2997

Fax+1 602-494-0481
Is this information wrong?

Summary

Board certified Dermatologist with expertise with general dermatology, MOHs surgery, psoriasis, clinical research, infectious diseases, and complex dermatological cases. I launched biologic drugs in Arizona with dermatologists and continue clinical research with psoriasis and atopic dermatitis. I am a clinical preceptor for both Midwestern university and A.T. Still medical schools. The development of new drugs is an interest of mine and I am proud to have been part of several new companies with drug development to positively affect patients suffering with psoriasis, eye diseases, cancer, and hypogonadism.

Education & Training

Cleveland Clinic FoundationResidency, Dermatology, 1994 - 1998
Northeast Ohio Medical UniversityClass of 1994

Certifications & Licensure

AZ State Medical License 1998 - 2026
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

ARIZONA BUSINESS MAGAZINE'S TOP 100 PHYSICIANS IN ARIZONA OVER ALL SPECIALTIES ARIZONA BUSINESS MAGAZINE, 2023
NEWSWEEK MAGAZINE'S TOP 150 DERMATOLOGISTS IN THE UNITED STATES NEWSWEEK MAGAZINE, 2022-2023
Phoenix Magazine's TOP DOCS 2020-2023
CASTLE CONNELLY'S Top Doctors in Dermatology In the United States Castle Connolly, 2012-2022
Phoenix Magazine TOP DOCS Phoenix Magazine, 2003-2015, 2017-2020
Fellow (FASDS) American Society for Dermatologic Surgery
Fellow (FAAD) American Academy of Dermatology
President Phoenix Dermatological Society Phoenix Dermatological Society
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis
Completed
Phase 2
Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis Start of enrollment: 2004 Jan 01
Completed
Phase 3
Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis Start of enrollment: 2003 Mar 01
Completed
Phase 2
PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis Start of enrollment: 2010 Sep 27
Completed
Phase 3
Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis Start of enrollment: 2012 Oct 01
Completed
Phase 3
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
Completed
Phase 3
A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis Start of enrollment: 2019 Feb 21
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

10 citations
Matching patients with therapy.
Joseph L. Jorizzo, Patrick S Carney, William T Ko, Perry Robins, Susan H Weinkle, Wm. Philip Werschler> ;Cutis. 2004 Dec 1
23 citations
Treatment options in the management of actinic keratosis.
Joseph L. Jorizzo, Patrick S Carney, William T Ko, Perry Robins, Susan H Weinkle, Wm. Philip Werschler> ;Cutis. 2004 Dec 1
11 citations
Fluorouracil 5% and 0.5% creams for the treatment of actinic keratosis: equivalent efficacy with a lower concentration and more convenient dosing schedule.
Joseph L. Jorizzo, Patrick S Carney, William T Ko, Perry Robins, Susan H Weinkle, Wm. Philip Werschler> ;Cutis. 2004 Dec 1